NQVAX
Price
$55.82
Change
-$0.99 (-1.74%)
Updated
Feb 21 closing price
Net Assets
483.81M
VMVAX
Price
$85.40
Change
-$0.97 (-1.12%)
Updated
Feb 21 closing price
Net Assets
30.89B
Ad is loading...

NQVAX vs VMVAX

Header iconNQVAX vs VMVAX Comparison
Open Charts NQVAX vs VMVAXBanner chart's image
Nuveen Multi Cap Value A
Price$55.82
Change-$0.99 (-1.74%)
VolumeN/A
Net Assets483.81M
Vanguard Mid-Cap Value Index Admiral
Price$85.40
Change-$0.97 (-1.12%)
VolumeN/A
Net Assets30.89B
NQVAX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NQVAX vs. VMVAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NQVAX is a Hold and VMVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. NQVAX (484M). VMVAX pays higher dividends than NQVAX: VMVAX (2.14) vs NQVAX (0.98). NQVAX was incepted earlier than VMVAX: NQVAX (22 years) vs VMVAX (13 years). NQVAX (22.00) and VMVAX (22.00) have comparable annual turnover. NQVAX has a lower initial minimum investment than VMVAX: NQVAX (2500) vs VMVAX (3000). NQVAX annual gain was more profitable for investors over the last year : 19.84 vs. VMVAX (12.44). NQVAX return over 5 years is better than : 81.49 vs. VMVAX (38.46).
NQVAXVMVAXNQVAX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years13 years-
Gain YTD2.5161.921131%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets484M30.9B2%
Annual Yield % from dividends0.982.1446%
Returns for 1 year19.8412.44160%
Returns for 3 years39.6115.34258%
Returns for 5 years81.4938.46212%
Returns for 10 years136.5181.26168%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDI9.96-0.02
-0.20%
DoubleDown Interactive Co Ltd
MANU14.46-0.15
-1.03%
Manchester United PLC
SRPT106.28-2.13
-1.96%
Sarepta Therapeutics
FTK8.22-0.20
-2.38%
Flotek Industries
ARTL1.16-0.04
-3.33%
Artelo Biosciences